The Stock Market Is Historically Expensive Right Now. Here's Why I'm Still Investing.

The article flags that the S&P 500’s CAPE ratio is at its highest level since 2000, implying historically rich valuation and potential risk that future earnings may not justify current prices. It argues long-term investors can still buy via diversification (mid/small caps and international stocks) and dollar-cost averaging, even if a 5%–10% pullback occurs.

Analysis

This is less a bearish macro call than a warning that passive market structure is increasingly fragile. When index-level valuation is being carried by a narrow leadership cohort, the first-order risk is not an instant crash but a period of flat-to-negative index returns as multiple compression offsets still-healthy earnings. That is why the more actionable signal is factor dispersion: equal-weight, value, and non-U.S. exposures should outperform if leadership breadth narrows even modestly.

The immediate market impact is probably muted because systematic DCA and benchmarked inflows keep buying cap-weighted U.S. beta on dips. The real risk window is 1-3 months, when any earnings disappointment, sticky rates, or a rotation out of AI winners can force de-risking in the same crowded names that dominate the index. If the top contributors simply keep beating, the valuation argument remains a poor timing tool and the trade loses urgency.

Contrarianly, the consensus may be overestimating how much "expensive" matters in a liquidity-rich regime and underestimating how long concentration can persist. The more important tell is whether earnings revisions broaden beyond mega-cap tech; if they do, the valuation premium can compress without a drawdown. If they do not, the next selloff is likely to be shallow until rates or growth data break the market's willingness to pay up.

Key Decisions for Investors

• Prefer a relative-value long IXUS / short QQQ or SPY basket for the next 1-3 months; the thesis is multiple-dispersion, not an outright market crash. Falsify if U.S. mega-cap earnings breadth expands materially or if QQQ continues to outperform IXUS by >5% on a rolling 4-week basis.
• Avoid initiating fresh broad-market beta at current levels; use pullbacks to add to diversified exposure rather than cap-weighted concentration. Best implemented via staged entries into VXUS/IXUS or equal-weight proxies instead of adding to SPY/QQQ momentum.
• If you need downside protection, buy 1-3 month SPY put spreads rather than naked puts; the expected move is a modest correction, not a tail event. Cover if breadth improves or if the index reclaims prior highs on rising participation.
• Watch the next earnings revision cycle as the real catalyst: if forward estimates stop rising for the top index contributors, rotate from cap-weighted U.S. beta into international and equal-weight exposure immediately. If estimates keep climbing, the valuation warning remains a watch item, not a sell signal.